Rezaei, S. & Ranjbar, S. (2024). Targeting the p53 Pathway in CAR-T Cell Engineering via Adenine Base Editing: A Safer Strategy for Cancer Immunotherapy. (e739552). Iranian Biomedical Journal, (), e739552
MLA
Rezaei, S., & Ranjbar, S. "Targeting the p53 Pathway in CAR-T Cell Engineering via Adenine Base Editing: A Safer Strategy for Cancer Immunotherapy" .e739552 , Iranian Biomedical Journal, , 2024, e739552.
HARVARD
Rezaei, S., & Ranjbar, S. (2024). 'Targeting the p53 Pathway in CAR-T Cell Engineering via Adenine Base Editing: A Safer Strategy for Cancer Immunotherapy', Iranian Biomedical Journal, (), e739552.
CHICAGO
Rezaei, S. & Ranjbar, S., "Targeting the p53 Pathway in CAR-T Cell Engineering via Adenine Base Editing: A Safer Strategy for Cancer Immunotherapy." Iranian Biomedical Journal, (2024): e739552,
VANCOUVER
Rezaei S., Ranjbar S. Targeting the p53 Pathway in CAR-T Cell Engineering via Adenine Base Editing: A Safer Strategy for Cancer Immunotherapy. Iranian Biomedical Journal. 2024;():e739552.
